Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 3 · 100%

Acute gout attacks · people with chronic gout

Febuxostat 40 mg/day showed no clear difference in incidence of gout flares compared with allopurinol (high certainty).

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
RR 0.97 [0.57, 1.65]
1 study · 1324 participants
High

Acute gout attacks · people with chronic gout

Febuxostat 80 mg/day showed no clear difference in incidence of gout flares compared with allopurinol (high certainty).

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
RR 1.1 [0.98, 1.3]
3 studies · 2325 participants
High

Acute gout attacks · people with chronic gout

Febuxostat 120 mg/day showed no clear difference in incidence of gout flares compared with allopurinol (high certainty).

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
RR 1.3 [0.87, 1.9]
2 studies · 986 participants
High